Cancer Research Coordinating Committee (CRCC) Funded Publications

Parent: University of California Research Initiatives

eScholarship stats: History by Item for March through June, 2025

ItemTitleTotal requests2025-062025-052025-042025-03
8ck6g0xpA DNA aptamer for binding and inhibition of DNA methyltransferase 1.915618107
9qw9t9zcStructure and function of G protein-coupled receptor oligomers: implications for drug discovery8438191413
0d34348tMetabolite Responsive Nanoparticle-Protein Complex7734151315
0ww2h0j5Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells75402186
3c03q2r2Rapid Enrichment and Detection of Extracellular Vesicles Enabled by CuS-Enclosed Microgels.713222107
6s658298Pre-clinical development of gene modification of hematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy6230101210
4wn320f9Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.602615109
7f71c92qInvestigations into Wnt modulation of p27(KIP1) turnover and the E3 ligase substrate adaptor DDB1 and CUL4 Associated Factor 4602616810
17k970vvSyrbactin Structural Analog TIR-199 Blocks Proteasome Activity And Induces Tumor Cell Death.59271787
17z5v0x6Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer59281876
3012r2z7Copy number networks to guide combinatorial therapy of cancer and proliferative disorders56281684
9wq0h1n3Adenosine A2a receptors form distinct oligomers in protein detergent complexes56271487
46n9603rScalable Total Synthesis, IP3R Inhibitory Activity ofDesmethylxestospongin B, and Effect on Mitochondrial Function andCancer Cell Survival5322111010
65m374m7Oil-in-Water-in-Oil Multinanoemulsions for Templating Complex Nanoparticles52251575
6476b5jsAutomatic Small RNA Extraction and Processing by a Multichannel/Multiwell Chip47231194

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.